Gene: SS18
Official Full Name: SS18 subunit of BAF chromatin remodeling complexprovided by HGNC
Gene Summary: Enables nuclear receptor coactivator activity. Involved in positive regulation of transcription by RNA polymerase II. Part of SWI/SNF complex. Implicated in synovial sarcoma. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01855 | SS18 Knockout cell line (HeLa) | Human | SS18 | 1:3~1:6 | Negative | Online Inquiry |
KO01856 | SS18 Knockout cell line (HCT 116) | Human | SS18 | 1:2~1:4 | Negative | Online Inquiry |
KO01857 | SS18 Knockout cell line (HEK293) | Human | SS18 | 1:3~1:6 | Negative | Online Inquiry |
KO01858 | SS18 Knockout cell line (A549) | Human | SS18 | 1:3~1:4 | Negative | Online Inquiry |
SS18 Gene Knockout Cell Lines are specialized cellular models engineered to exhibit complete disruption of the SS18 gene, a critical component implicated in various oncogenic processes. This innovative product leverages the power of CRISPR-Cas9 gene-editing technology to precisely induce targeted mutations in the SS18 gene, leading to the establishment of knockout cell lines that effectively model the gene's loss of function in a controlled environment.
These cell lines serve as invaluable tools for dissecting the biological roles of the SS18 gene in cellular pathways, particularly in the context of cancer research. By observing the phenotypic and functional changes in SS18-deficient cells, researchers can elucidate the mechanisms underlying tumorigenesis and identify potential therapeutic targets. Furthermore, the SS18 Gene Knockout Cell Lines can support high-throughput screening assays, enabling the discovery of novel compounds or genetic interactions that may regain control over aberrant signaling pathways.
What sets these cell lines apart is their superior reliability and authenticity in replicating the physiological conditions of human tissues. In contrast to traditional knockdown strategies, which only partially reduce gene expression, the knockout approach provides complete functional ablation, offering clear insights into gene function and regulation. Additionally, these cell lines are rigorously validated for consistent performance across various assays, ensuring reproducibility and accuracy in research outcomes.
For researchers and clinicians alike, the SS18 Gene Knockout Cell Lines represent a significant advancement in experimental biology. Their application extends beyond understanding SS18’s role in cancer, providing foundational models for exploring broader implications in developmental biology and genetic disorders. With a focus on innovation and excellence, our company brings extensive expertise in cellular model development, assuring customers that they are equipped with reliable, high-quality products to support their pioneering research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.